用黄金香料库尔库明准内皮细胞:对于心脏代谢多病症来说,这是一个有希望的治疗方法
Fei Tang1, Dong Liu1, Li Zhang1
1Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Pharmacological research
|October 7, 2023
概括
黄素是一种天然化合物,通过保护内皮细胞,显示出治疗心脏代谢多病症 (CMM) 的前景. 这种食补充剂针对CMM进展的多个途径,提供潜在的治疗益处.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
- 营养保健品 营养保健品
背景情况:
- 心脏代谢多病症 (CMM) 涉及多种疾病,如高血压,中风,心脏病,动脉样硬化和2型糖尿病 (T2DM).
- 内皮功能障碍,以氧化应激,炎症和异常的氧化 (NO) 生物可用性为特征,是CMM发展的核心因素.
- 向内皮细胞为预防和治疗CMM提供了一个有希望的策略.
研究的目的:
- 审查黄素对CMM的治疗潜力.
- 探索黄素对内皮细胞的分子点和作用机制.
- 讨论黄素对CMM的临床翻译挑战和未来前景.
主要方法:
- 关于黄素在CMM中的特性和治疗应用的综合文献综述.
- 对调查黄素分子标的研究进行分析 (例如NF-κB,MAPK,HO-1,NOs,VEGF,ICAM-1,ROS).
- 评估黄素的药理动力学,药物和临床证据,用于CMM治疗.
主要成果:
- 库尔库显示了与内皮细胞的多目标和多途径相互作用.
- 它通过减轻氧化应激,炎症和改善NO生物可用性来有效调节内皮功能.
- 已识别的分子标包括NF-κB/PI3K/AKT,MAPK/NF-κB/IL-1β,HO-1,NOs,VEGF,ICAM-1和ROS等.
结论:
- 由于其对内皮细胞的保护作用,黄素在CMM管理方面显示出显著的治疗前景.
- 作为一种天然化合物,黄素代表了开发有效CMM治疗的新.
- 需要进一步的临床研究来克服挑战,并实现黄素在CMM中的全部治疗潜力.
相关概念视频
01:26Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
01:27Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
180
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
180
01:30Coronary Artery Disease I: Introduction
19
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
19